Author: admin

  • Dozens of ‘ghost galaxies’ may be orbiting the Milky Way

    Dozens of ‘ghost galaxies’ may be orbiting the Milky Way

    Our galaxy may be wrapped in a richer swarm of tiny companions than astronomers have ever seen. New calculations predict that there are dozens of ultra-faint satellite galaxies circling close to the Milky Way.

    They are too dim for current surveys to spot, but real enough to tip the cosmic balance sheet in favor of standard cosmology.


    The forecast comes from cosmologists at Durham University. By combining the sharpest supercomputer simulations available with new mathematical modeling, the team argues that up to 100 additional satellites should be lurking nearby.

    Many are likely to be “orphan” galaxies, almost entirely stripped of the dark matter cocoons that once cradled them. This twist could finally resolve a long-standing mismatch between theory and observation.

    The Milky Way’s ghost galaxies

    The study begins with the Lambda Cold Dark Matter framework. In this model, roughly five percent of the cosmos is ordinary matter, twenty-five percent is cold dark matter, and the remaining seventy percent is dark energy.

    In this model, galaxies shine from the centers of vast dark-matter halos. Most star systems in the Universe are low-mass dwarf galaxies bound to a more massive host.

    The problem is that classic LCDM computations generate far more dwarf satellites than astronomers have cataloged around the Milky Way. Either the model is wrong or the satellites are missing.

    To probe that gap, the Durham group turned to the Aquarius simulation, the highest-resolution model yet of a Milky Way-like dark-matter halo. The team also used GALFORM, a code that tracks gas cooling, star formation, and feedback.

    Even top tools miss tiny halos when they near the galaxy and feel its tidal pull. Analytical fixes revived erased halos, letting researchers track their stellar remnants across 13 billion years.

    Lost galaxies cluster nearby

    The key insight is that the galaxies whose halos entered the Milky Way’s neighborhood early have spent eons being stretched, prodded, and shaved by gravity. Their dark matter bleeds away first; their stars shrink into faint knots that simulations often drop but nature should keep.

    The models suggest that these ghostly remnants have orbital histories similar to the brighter satellites we already know. They tend to cluster within a few hundred thousand light-years of the galactic center.

    Because they are faint and sparse, current imaging misses them, but the Vera C. Rubin Observatory’s LSST camera, now undergoing commissioning, should pull many into view.

    “We know the Milky Way has some 60 confirmed companion satellite galaxies,” said lead author Isabel Santos-Santos, a cosmologist at Durham. “We think there should be dozens more of these faint galaxies orbiting around the Milky Way at close distances.”

    If their predictions are correct, it strengthens support for the Lambda Cold Dark Matter theory of how structure in the Universe forms and evolves.

    “Observational astronomers are using our predictions as a benchmark with which to compare the new data they are obtaining,” she said. “One day soon, we may be able to see these ’missing’ galaxies, which would be hugely exciting and could tell us more about how the Universe came to be as we see it today.”

    Future images of the Milky Way

    Over the past decade, wide-field cameras such as the Dark Energy Survey have turned up about thirty ultra-faint satellite candidates.

    Yet astronomers still debate whether these specks are true dwarf galaxies embedded in dark matter or merely star-cluster outliers.

    The study argues that many of them – and many more beyond – should indeed be galaxies, the visible tips of dark-matter fragments pared to the bone.

    Future deep imaging and stellar-population studies will be critical for deciding which candidates carry dark matter signatures such as elevated velocity dispersions.

    Finding the Milky Way’s ghost galaxies

    “If the population of very faint satellites that we are predicting is discovered with new data, it would be a remarkable success of the LCDM theory of galaxy formation,” said co-author Carlos Frenk, a professor of computational cosmology at Durham.

    “Using the laws of physics, solved using a large supercomputer, and mathematical modelling we can make precise predictions that astronomers, equipped with new, powerful telescopes, can test.”

    Validating the prediction would also quiet doubts raised by the so-called “missing satellite” and “too-big-to-fail” problems – tensions often cited as cracks in LCDM.

    If the Milky Way does host scores of nearly invisible ghost galaxies, then the theory’s tally of dark-matter clumps stands. What looked like a failure of physics may be a failure of detection.

    Ghosts become neighbors

    With LSST set to map the southern skies to unprecedented depths, the hunt for hidden satellites is gaining momentum. Other instruments, such as the European Space Agency’s Euclid telescope, will help sharpen the picture.

    New algorithms tuned to pick out diffuse, low-surface-brightness objects will scan the LSST deluge, guided by the locations and properties the Durham models predict.

    Discovering even a fraction of the proposed “orphan” galaxies would give cosmologists a richer lab for testing how dark matter behaves on small scales and how starlight survives in extreme environments.

    It would also remind us that the Milky Way, though serene to the naked eye, belongs to a teeming, fragile community of companions.

    For now, they remain ghosts in a computer. But new telescopes may soon reveal them as real, stellar neighbors, deepening our understanding of how galaxies, large and small, take shape in the dark.

    The research was presented at the National Astronomy Meeting of the Royal Astronomical Society.

    Image Credit: The Aquarius simulation, the Virgo Consortium/Dr. Mark Lovell

    —–

    Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

    Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

    —–


    Continue Reading

  • The markets are telling you not to worry with steep drop in volatility. Should you listen?

    The markets are telling you not to worry with steep drop in volatility. Should you listen?

    Continue Reading

  • Mpox Outbreaks May Diminish With Expanded Vaccine Access — Vax-Before-Travel

    Mpox Outbreaks May Diminish With Expanded Vaccine Access — Vax-Before-Travel

    (Vax-Before-Travel News)

    The World Health Organization (WHO) published the 55th situation report for the multi-country outbreak of mpox virus (MPXV), which provides details on the global epidemiological situation for mpox, including an update in Africa.

    All clades of MPXV continue to circulate in several countries.

    On July 11, 2025, the WHO stated that only Türkiye has reported the detection of a new MPXV sub-clade since report #54, in a traveler from the Democratic Republic of the Congo (DRC).

    In Africa, community transmission of clade Ib MPXV remains limited to 19 countries. Most countries with previous sporadic importations are currently not reporting active transmission of clade Ib MPXV.

    As of July 8, 2025, the countries of Burundi, DRC, Ethiopia, Kenya, Malawi, Rwanda, South Sudan, Tanzania, Uganda, and Zambia are experiencing sustained human-to-human transmission of the virus.

    Clade IIb MPXV continues to be reported in West Africa, while Central African countries report both clade Ia and clade Ib MPXV, and East African countries report clade Ib MPXV.

    The WHO noted that, despite progress in response activities implemented through collaboration among governments, international partners, and communities, significant funding gaps are threatening the deployment of vaccines.

    Approximately 724,000 MVA-BN (JYNNEOS) vaccine doses had been administered in 7 countries, out of the 1.9 million vaccine doses allocated to 13 countries, partly due to funding requirements for shipping to the countries.

    Additionally, the DRC had received 1.55 million doses of the LC16m8 vaccine from a bilateral agreement.

    In the United States, the JYNNEOS vaccine has become readily available at travel clinics and pharmacies and is recommended for specific international travelers.

    Continue Reading

  • 4 factors may influence weight loss results

    4 factors may influence weight loss results

    Share on Pinterest
    Some people may experience more successful weight loss while taking GLP-1s. Scientists are trying to uncover why. Steve Christo – Corbis/Corbis via Getty Images
    • Research on weight loss medications, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs), and why people experience varying results is ongoing.
    • One study helped identify multiple components that may affect successful weight loss among people using GLP-1RAs.
    • The researchers found that taking the medication for longer and starting on semaglutide rather than other GLP-1RA options produced more successful weight loss results.

    The results suggest that factors like taking GLP-1RAs longer, having greater accumulated exposure to GLP-1RAs, using semaglutide, and not having diabetes may make it more likely for some people to experience successful weight loss from GLP-1RA use.

    This research involved a total of 679 participants and was a retrospective cohort study. All participants were overweight or obese, and this was determined by body mass index (BMI). Some participants also had type 2 diabetes. All participants had at least three months’ worth of follow-up and at least three noted weight measurements during the follow-up.

    Researchers had data from participants’ follow-up visits, including factors like body composition and measurements of liver and kidney function. Their data looked at treatment with seven different GLP-1RAs, including semaglutide, lixisenatide, and liraglutide.

    Researchers examined weight fluctuation among participants and divided participants into three groups: successfully losing weight, staying the same weight, or regaining weight. In their analyses, they then further classified participants as having successful or unsuccessful weight reduction. The unsuccessful category included both weight regain and staying the same weight.

    Researchers did their analyses at three months, six months, and then at one year. The average age of participants was thirty-seven years old, and about 21% of participants had diabetes.

    Participants who had been on GLP-1RAs for longer were more likely to experience successful weight reduction at six and twelve months. At the three and six-month marks, participants who experienced successful weight reduction were also less likely to have diabetes and more likely to start their treatment on semaglutide.

    At the three-month follow-up, participants in the weight regain group also had higher estimated glomerular filtration rates, which measures kidney function. This was also true when looking at just participants with prediabetes. The authors note that people with obesity can experience these higher filtration rates, which can then lead to worse kidney function.

    Researchers also observed that the group that remained stable had higher fasting plasma glucose levels than the other groups and worse beta cell function and insulin resistance than participants who successfully lost weight.

    In their univariate logistic regression analysis, the researchers identified several factors that may be related to successful weight loss. These included longer time on GLP-1RA treatment, semaglutide use, lower blood sugar levels, and a higher percentage of body fat.

    They also observed that greater Homeostasis Model Assessment of β-Cell Function levels, which helps to measure beta cell function in the pancreas and insulin resistance, was associated with successful declines in weight.

    For women, having a lower skeletal muscle mass was also associated with successful weight reduction.

    After adjusting for age, sex, and BMI, the researchers found that the longer people used GLP-1RAs, the more they lost weight successfully at all the follow-up time points. At three and six months, starting semaglutide, compared to other GLP-1RAs, was linked to successful weight loss.

    For men, having a body fat percentage greater than 30% was associated with successful weight reduction at three months, but this was not the case for women. At three months, not having diabetes and hemoglobin A1C levels were linked to successful weight loss.

    In addition to these factors, researchers also observed some non-linear associations. For example, some measurements of muscle mass and basal metabolic rate had a reversed J-shaped association with successful weight loss.

    Subgroup analyses also revealed that higher accumulated exposure of semaglutide or liraglutide were both associated with successful weight reduction. At three months, liraglutide and semaglutide users with successful weight reduction had higher fasting plasma glucose levels. For men on semaglutide, having a greater percentage of body fat was associated with successful weight loss at a six-month follow-up.

    This study does have benefits and potential limitations. Paunel Vukasinov, MD, a dual board-certified Internist and Obesity Medicine Specialist with Medical Offices of Manhattan and contributor to Labfinder.com, who was not involved in the research, noted the following to Medical News Today:

    “This study offers helpful information about the differences in weight loss results for patients treated with GLP-1 receptor agonists (GLP-1RAs). Clinical trials have shown that GLP-1RAs work well, but this study points out the varied responses in everyday clinical settings. It also tries to find the reasons behind this variability.”

    “However, the lack of randomization, possible confounding factors, and the single-center design do weaken the conclusions. Still, it addresses an important clinical question: why do some patients do well on GLP-1RAs while others stop losing weight or regain it? It encourages us to move toward more personalized obesity care.”
    — Paunel Vukasinov, MD

    This study was conducted among Chinese participants receiving treatment at a single weight loss clinic. Data from other countries may be helpful in future research.

    Researchers note that only 112 participants had a follow-up assessment at the one-year mark. They also note there was a lack of record for some possible confounding factors and that they weren’t able to assess how lifestyle interventions throughout the follow-up could have affected outcomes. Another limiting factor was that “longitudinal data for body composition was not systematically collected and analyzed at the follow-ups.”

    Treatment discontinuation did happen, which meant differences in medication patterns.

    When looking specifically at the use of semaglutide and liraglutide in the subgroup analyses, researchers only analyzed the data from the three-month and six-month follow-ups. They were also only able to look at accumulated exposure for two types of GLP-1RAs.

    Participants without type 2 diabetes had more limited access to GLP-1RAs, and this could have influenced the study’s results. One author also noted conflicts of interest.

    Selena Raines, DO, an osteopathic physician specializing in family medicine and American Osteopathic Association member, who was also not involved in the study, noted the following limits of this study to Medical News Today:

    “It’s important to note the limitations, namely, the small sample size and the even smaller number of participants who continued through the full 12-month follow-up period…This paper does not explore the effects of discontinuation, a crucial aspect given evidence showing significant weight regain in many individuals once GLP-1RAs are stopped, even with continued lifestyle modifications. Nor does it include tirzepatide, which, while not solely a GLP-1RA, currently shows even more promising data for weight loss than semaglutide in existing trials.”

    More research is required to examine some of the components of the study, such as the differences in weight loss for people with diabetes compared to those without diabetes. More research on how kidney function plays into everything may also be helpful.

    The authors of this study suggest that data from this study could help make the use of GLP-1RAs more precise.

    It might help improve the success related to these medications. Kais Rona, MD, a bariatric surgeon of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who was also not involved in the study, noted the following:

    “Ultimately, this study supports a personalized approach to the use of GLP-1RA medications. One that identifies important physiologic markers prior to the initiation of the treatment regimen, monitors patient response over time, and focuses on long-term success.”

    The research also highlights the importance of careful clinical oversight when people use GLP-1RAs.

    “Many patients are currently receiving these medications from providers outside their primary care home, often without comprehensive management or long-term planning. This raises concerns about suboptimal outcomes and unintended side effects…What we now need are more long-term studies, particularly focused on sustained outcomes, strategies for maintenance after discontinuation, and optimizing individualized care,” Raines said.

    Continue Reading

  • How to Get Tempestuous Mutation in Grow a Garden

    How to Get Tempestuous Mutation in Grow a Garden

    With the latest update in Grow a Garden, we have a brand new Tempestuous mutation that is quite challenging to obtain. To get this mutation, you will need your plants to combine not two but three different mutations at once. So, there are a few tricks that can help in obtaining this mutation more easily. Now that you’re curious about getting the Tempestuous mutation in Grow a Garden, check out our detailed guide below.

    How to Get the Tempestuous Mutation in Grow a Garden

    The Tempestuous mutation is not directly tied to any particular weather event or pet in Grow a Garden. Rather, in order to successfully get this mutation, a fruit must have the three mutations: Windstruck (2x), Twisted (5x), and Sandy (3x), all at once.

    Yes, your fruit needs to gain all three mutations to be able to convert it into Tempestuous (12x). This is why it is way more difficult to obtain than any other mutation. It will require a strategic approach to obtain this mutation.

    Image Credit: Grow a Garden/Roblox (screenshot by Ishan Adhikary/Beebom)

    The Tempestuous mutation gives your fruits a white wind particle animation. So don’t worry, if looking at your harvests feels like they have got some light shaded bugs in it. It would most probably be this mutation.

    The Tempestuous mutation increases the sale value of fruits by 12 times, so it’s a pretty decent haul if the base value is good. You may also go through the list of Grow a Garden mutations to know what all can help in making money fast in the game.

    Tempestuous Mutation Stats
    Image Tempestuous Mutation Grow a Garden
    Multiplier 12x
    Obtained from Combining Windstruck, Twisted, and Sandy

    Best Tips to Get Tempestuous Mutation in Grow a Garden

    Since the Tempestuous Mutation is not directly linked to any special weather event, it’s a matter of patience before you get a fruit with it. You must wait till the fruit or harvest gets all three mutations altogether. So, here are some tips to get the Tempestuous mutation faster in the game.

    1. Plant Mult-Harvest Crops

    In order to get more Tempestuous mutations on your harvests, you can consider planting a greater number of multi-harvest crops in your plot. This ensures that you don’t need to manage your crops a lot by getting inside the game. Also, make sure that you plant those crops that give multiple yields at a single time, like the following:

    2. Manage Crops Before the Event Starts

    Firstly, I highly recommend using the Favorite tool to lock some of the best and high-value fruits in your garden. This way, you won’t accidentally pick up the harvests that have any one of the required mutations for the Tempestuous one.

    You can also use other Grow a Garden gears, such as sprinklers, to maximize the size of fruits and harvests that you wish to get this sort of mutation in the game. Lastly, I would recommend you to shovel lower value plants like strawberries, blueberries to prevent them from getting the required mutations for getting Tempestuous on them.

    Should You Try to Get Tempestuous Mutation?

    Now you know all the steps to get the Tempestuous mutation in Grow a Garden. Next comes the real question: Should you go through these efforts to get this mutation?

    Since the Tempestuous mutation only increases the value by 12 times, and requires 3 rare mutations to be applied to a fruit, it seems a lot of task just for a meager money boost.

    Surely, if any of the single harvest plants like the Boneboo or Bendaboo have this sort of mutation, it will be a good increase in price. You can get rich in no time as well. Moreover, if you’re a player who likes leaving the game on for a while, be AFK or do your other tasks, surely getting this mutation is easy. However, if you’re an active player, it makes no sense to go after this mutation.

    So, have you got this mutation in the game? Let us know in the comments below!

    Bipradeep Biswas

    A Computer Science graduate with a passion for gaming, currently specializing in Minecraft and popular Roblox games.


    Continue Reading

  • FM Araqchi says Iran to work with IAEA, but inspections may be risky – Reuters

    1. FM Araqchi says Iran to work with IAEA, but inspections may be risky  Reuters
    2. Iran tells IAEA to end ‘double standards’ before nuclear talks can resume  Al Jazeera
    3. Consequences Unfold  War on the Rocks
    4. ‘Firmer reprisal’ awaits aggressors, Pezeshkian warns while demanding IAEA reform  Tehran Times
    5. Iran says cooperation with UN nuclear watchdog ‘will take on a new form’  The Hindu

    Continue Reading

  • July 12, 1988: Phobos 2 launches

    July 12, 1988: Phobos 2 launches

    Today in the history of astronomy, a Soviet probe heads for Mars.

    • Phobos 2 was a Soviet probe sent to study Mars and its moons.
    • It carried many scientific instruments to gather data.
    • Phobos 2 reached Mars but lost contact before completing its mission.

    The Soviet Union launched Phobos 2 on July 12, 1988, the second of two uncrewed probes designed to study Mars, moons Phobos and Deimos, the Sun, and the interplanetary environment. Each probe was equipped with 25 instruments including high-energy detectors; X-ray and solar photometers; infrared, ultrasound, and gamma-ray spectrometers; and more. Phobos 1 was lost en route on Sept. 2, when an error in a command sequence caused it to lose its ability to maintain its orientation; its batteries eventually were depleted and it shut down. While Phobos 2 did successfully reach Mars and gathered data on the Sun, Mars, and Phobos, contact was lost with the probe in March 1989 when the onboard computer failed. Unfortunately, the malfunction occurred before its planned maneuver to closely approach Phobos and launch landers on its surface.

    Continue Reading

  • Top 5 Infectious Disease News Stories Week of July 5-12

    Top 5 Infectious Disease News Stories Week of July 5-12

    Universal Hepatitis C Screening in EDs Detects More Infections, but Gaps in Care Remain

    The DETECT Hep C trial, recently published in JAMA, demonstrates that universal (nontargeted) hepatitis C screening in emergency departments (EDs) identifies significantly more new HCV infections than traditional risk-based screening—154 vs. 115 cases among over 147,000 visits. However, despite the higher detection rate, linkage to care and treatment completion remain critically low, with fewer than 10% of diagnosed patients achieving a cure (SVR12). Barriers include homelessness, patient disengagement, and the passive nature of clinician referrals. The study, conducted across EDs in Denver, Baltimore, and Jackson, highlights the ED’s untapped potential as a key access point for underserved populations but also points to systemic failures in the HCV care continuum. Experts like Dr. Jason Haukoos call for innovative care models, such as “warm hand-offs” and integrated follow-up, to improve outcomes. These findings align with the CDC’s 2025 recommendations endorsing universal HCV screening for all adults and pregnant women, reinforcing the need for low-barrier, stigma-free approaches in high-volume clinical settings.

    A Young Mother With C difficile Deals With Social Isolation, Concerns of Recurrence

    In this deeply personal account, Sara Embry shares her traumatic experience contracting Clostridioides difficile (C diff) while newly pregnant, despite never taking antibiotics. Likely exposed via fecal spores at a restaurant, Embry describes the physical toll of rapid weight loss and extreme weakness, as well as the emotional isolation of being contagious around her family, particularly her two young children. She received little guidance from healthcare providers and struggled with the fear of recurrence long after her recovery. Her turning point came when she found the Peggy Lillis Foundation (PLF), which offered not only practical support but emotional connection. Inspired, she now works as a peer support volunteer, helping others navigate the disease. Embry emphasizes the need for greater public and provider awareness of C diff, which she argues is not rare and can affect healthy individuals. She calls for better education, responsible antibiotic prescribing, and patient-centered care, advocating through PLF to ensure no one faces the illness alone.

    Carl Schmid on Supreme Court Ruling Upholding ACA Preventive Coverage and Its Impact on HIV Prevention

    In a pivotal 6-3 ruling, the US Supreme Court upheld the Affordable Care Act’s (ACA) mandate requiring private insurers to cover preventive services recommended by the US Preventive Services Task Force (USPSTF) without cost-sharing. The decision in Kennedy v Braidwood Management safeguards access to critical services, including HIV testing, hepatitis screening, and pre-exposure prophylaxis (PrEP), for millions of Americans. Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, praised the ruling as a significant victory for public health, emphasizing that prevention has long been a bipartisan priority within the ACA. The lawsuit, rooted in ideological opposition to PrEP, threatened to unravel coverage protections, especially for those relying on employer-sponsored insurance. While the decision preserves the legal requirement, Schmid warned that compliance issues persist, particularly regarding insurers’ handling of newer PrEP options like long-acting injectables. He stressed that enforcement and public awareness are now essential to ensure equitable access to the full range of preventive care benefits.

    Structural Barriers Drive Racial Disparities in Outpatient COVID-19 Treatment

    A new study published in JAMA Network Open finds that Black and Latino patients were significantly less likely than White patients to receive timely outpatient COVID-19 antiviral treatment, by 10.8 and 9.8 percentage points, respectively. Coauthored by Rebecca Bromley-Dulfano, MS, the research attributes over half of this disparity to structural and encounter-level factors, such as limited access to home testing, virtual care, and differences in clinic infrastructure. Black and Latino patients were less likely to use rapid antigen tests or engage in virtual visits, associated with faster treatment. The findings suggest these disparities are not solely due to individual clinical differences but reflect broader, modifiable system-level inequities. Bromley-Dulfano emphasized that expanding access to telehealth and rapid testing, particularly in underserved clinics, could significantly reduce racial gaps in treatment. The authors call for targeted health system investments to improve equitable access to COVID-19 care across diverse populations.

    PREPARE Trial: Over Half of Middle-Aged Adults With HIV Experience Physical Function Decline

    A new analysis from the PREPARE trial found that over half of middle-aged adults living with HIV experienced physical function decline, with key risk factors including older age, female sex, non-White race, higher BMI, prior depression treatment, and elevated inflammatory markers like IL-6 and hsCRP. Researchers linked this decline to chronic inflammation, co-infections such as cytomegalovirus, and side effects from certain antiretroviral therapies (ART). The study emphasizes the importance of routine screenings, such as gait speed and chair rise tests, to identify early signs of impairment, and highlights the vital role infectious disease specialists can play in preventing disability by recognizing risk factors and coordinating timely, multidisciplinary care.

    Continue Reading

  • Saudi Riyal to Pakistani Rupee Rate; July 12, 2025

    Saudi Riyal to Pakistani Rupee Rate; July 12, 2025

    KARACHI, July 12, 2025 – The Saudi Riyal (SAR) has gained ground against the Pakistani Rupee (PKR) in the open market, climbing to a buying rate of Rs75.82 today, a slight dip from Rs75.86 on July 11 but still above the July 8 rate of Rs75.79 and last week’s close of Rs75.69, currency traders report.

    The selling rate also adjusted to Rs76.39. This subtle shift, propelled by consistent remittance streams and periodic market demand, emphasizes the Riyal’s pivotal influence on Pakistan’s financial landscape.

    1 Saudi Riyal= 75.82 Pakistani Rupee

    Significance of the Saudi Riyal for Pakistan

    The Saudi Riyal is a bedrock for Pakistan’s economy, underpinned by the robust ties with Saudi Arabia, where millions of Pakistani workers are employed in fields like construction, medical services, and hospitality. These expatriates remitted $913.3 million in May 2025, positioning Saudi Arabia as the leading source of Pakistan’s remittance inflows, according to the State Bank of Pakistan. Between July 2024 and May 2025, remittances soared to $34.9 billion, a 28.8% surge from the prior fiscal year. At today’s rate of Rs75.82, converting 1,000 Saudi Riyals yields Rs75,820, compared to Rs75,860 yesterday, directly enhancing the livelihoods of families dependent on these funds for schooling, healthcare, and daily needs.

    Saudi Riyal Rate-Daily Updates

    Economic Ripple Effects of the Rate Shift

    The Saudi Riyal’s adjustment to Rs75.82 carries both immediate and far-reaching consequences. For households, the Riyal’s strength amplifies the value of remittances, bolstering spending power amid escalating costs. Enterprises trading with Saudi Arabia, especially in oil and chemical imports, benefit from the Riyal’s steady value, which ensures cost predictability, though a stronger Riyal may marginally inflate import expenses, straining Pakistan’s trade balance. On a broader scale, the Riyal’s stability fortifies Pakistan’s foreign exchange reserves, which exceeded $11 billion in October 2024, aiding in curbing inflation and servicing external debt. A softer Rupee, as seen earlier in June, can enhance export potential, but the current stability in the Riyal-PKR pair fosters economic equilibrium.

    Overview of the Saudi Riyal and Pakistani Rupee

    The Saudi Riyal (SAR), divided into 100 halala, serves as Saudi Arabia’s currency, overseen by the Saudi Central Bank and anchored to the US dollar for reliability. This stability makes it a trusted medium for global commerce and remittances, especially for Pakistanis working in the Kingdom. The Pakistani Rupee (PKR), marked by ₨, has been Pakistan’s currency since 1948, managed by the State Bank of Pakistan under a flexible exchange rate system. Its value hinges on domestic factors like inflation, trade deficits, and foreign inflows, with the Riyal-PKR rate shaped by market forces.

    What Lies Ahead

    The Saudi Riyal’s ascent to Rs75.82 reflects enduring market momentum, fueled by remittances and trade flows. Traders and economic planners should remain attentive, as even slight rate changes can affect remittances, import costs, and fiscal strategies. For countless Pakistanis, both domestically and abroad, the Riyal’s steadfast value remains a cornerstone of financial security and economic resilience.

    Sources: State Bank of Pakistan, Forex Association of Pakistan


    Continue Reading

  • Suture Techniques for Traumatic Wound Closure in the Emergency Department: A Systematic Review of Cosmetic, Functional, and Infection-Related Outcomes

    Suture Techniques for Traumatic Wound Closure in the Emergency Department: A Systematic Review of Cosmetic, Functional, and Infection-Related Outcomes


    Continue Reading